SCHEMBL5016189

SCHEMBL5016189

[O]c1nc2cc(N3CCN(CCCc4ccc(C(F)(F)F)cc4)CC3)ccc2s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.49
SIGMAR1 Q99720 4/20 0.47
CETP P11597 1/20 0.47
HTR2C P28335 3/20 0.47
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
DRD2 P14416 4/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43
THPO P40225 1/20 0.43
MTOR P42345 1/20 0.43
BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5013286 0.96 HTR1A (0.51) HTR1ASIGMAR1CETPHTR2CADRA1D
SCHEMBL5012728 0.89 SIGMAR1 (0.52) HTR1ASIGMAR1CETPHTR2CADRA1D
SCHEMBL2095906 0.85 MAOB (0.38) HTR1ASIGMAR1CETPHTR2CSLC6A4
SCHEMBL2094724 0.83 HTR1A (0.37) HTR1ASIGMAR1CETPHTR2CSLC6A4
SCHEMBL27644378 0.82 SIGMAR1 (0.49) HTR1ASIGMAR1CETPHTR2CADRA1D
SCHEMBL5536058 0.78 ADRA1D (0.57) HTR1ASIGMAR1CETPHTR2CADRA1D
SCHEMBL27645223 0.77 SIGMAR1 (0.54) HTR1ASIGMAR1CETPHTR2CADRA1D
SCHEMBL2093048 0.77 LRRK2 (0.38) HTR1ASIGMAR1CETPHTR2CMAPT
SCHEMBL5539608 0.75 SIGMAR1 (0.58) HTR1ASIGMAR1HTR2CADRA1DADRA1A
SCHEMBL5012696 0.74 SIGMAR1 (0.46) HTR1ASIGMAR1HTR2CADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 EP disclosed